Sprains and Strains
A collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature.
Subtype terms (1)
More specific conditions that are subtypes of Sprains and Strains in the MeSH hierarchy.
- Cumulative Trauma Disorders
3 drugs (2 approved, 1 experimental)
Drugs by status
Approved for this indication (13)
Phase 4 trials (13)
Phase 3 trials (25)
Phase 2 trials (15)
Phase 1 trials (3)
Other trials (31)
- maltodextrin
- aloe vera
- acetylcysteine
- beta-hydroxyisovaleric acid
- cefixime
- somatropin
- mesalamine
- whey protein
- levocarnitine
- naproxen
- cow milk
- pterostilbene
- oritavancin
- vancomycin
- nicotinamide
- aronia extract
- ashwagandha extract
- fenugreek extract
- gynostemma pentaphyllum
- fentanyl
- amino acids
- moxifloxacin
- soybean
- sodium bicarbonate
- verbena
- protein hydrolysates
- turmeric
- omega-3 fatty acids
- ferrous sulfate
- branched chain amino acids
- +1 more
Organizations
Organization Involved with Phase 4 Indications (14)
- McNeil
- Merck
- Pfizer
- GlaxoSmithKline
- University of Arizona
- Akdeniz University
- Núcleo de Estudos em Esportes e Ortopedia, Brazil
- Pamukkale University
- University of Cape Town
- University of Naples Frederico II
- Rundo International Pharmaceutical Research & Development Co.,Ltd.
- Johnson and Johnson
- Government of Taiwan
- Federico II University
Organization Involved with Phase 3 Indications (16)
- PPD
- Actavis
- Kowa
- Novartis
- Biologische Heilmittel Heel GmbH
- Cerimon Pharmaceuticals
- Endo Pharmaceuticals
- Hisamitsu Pharmaceutical Co., Inc.
- Laboratório Teuto Brasileiro S/A
- Strategic Science & Technologies, LLC
- Faculdade de Medicina do ABC
- Laboratorio Brasileiro de Biologia
- East Carolina University
- S.C. Corinthians Paulista
- ABC Foundation School of Medicine
- MEDRx Co., Ltd.
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (10)